Lead poisoning can cause a wide range of symptoms with particularly severe clinical effects on the CNS. Lead can increase spontaneous neurotransmitter release but decrease evoked neurotransmitter release. These effects may be caused by an interaction of lead with speci®c molecular targets involved in neurotransmitter release. We demonstrate here that the normally calcium-dependent binding characteristics of the synaptic vesicle protein synaptotagmin I are altered by lead. Nanomolar concentrations of lead induce the interaction of synaptotagmin I with phospholipid liposomes. The C2A domain of synaptotagmin I is required for lead-mediated phospholipid binding. Lead protects both recombinant and endogenous rat brain synaptotagmin I from proteolytic cleavage in a manner similar to calcium. However, lead is unable to promote the interaction of either recombinant or endogenous synaptotagmin I and syntaxin. Finally, nanomolar concentrations of lead are able to directly compete with and inhibit the ability of micromolar concentrations of calcium to induce the interaction of synaptotagmin I and syntaxin. Based on these ®ndings, we conclude that synaptotagmin I may be an important, physiologically relevant target of lead.
. Symptoms can include learning disorders, IQ reduction, hyperactive behavior, ataxia and convulsions (Needleman et al. 1990; Bressler and Goldstein 1991; Finkelstein et al. 1998) . According to the Centers for Disease Control, a blood Pb 21 level of 10 mg/dL is`concerning' (Centers for Disease Control 1991, Centers for Disease Control and Prevention. 1997) . Approximately 8.9% of children in the United States alone exceed that threshold (Goldstein 1992; Needleman 1994 Needleman , 1998 Bressler et al. 1999) making Pb 21 one of the most widely prevalent environmental causes of preventable neurological disorders (Landrigan and Todd 1994) .
The clinical effects of Pb 21 on the CNS may be due in part to its ability to alter neuronal activity. Pb 21 decreases evoked and increases spontaneous neurotransmitter release in a variety of neuronal preparations including synaptosomes, cell cultures and brain slices (Manalis and Cooper 1973; Carroll et al. 1977; Suszkiw et al. 1984; Tomsig and Suszkiw 1993; Bielarczyk et al. 1994; Struzynska and Rafalowska 1994; Bressler et al. 1996; Bressler et al. 1999) . These effects are presynaptic (Manalis and Cooper 1973) and have been observed in dopaminergic , GABAergic , glutamatergic (Busselberg et al. 1994; Guilarte 1997a; Guilarte 1997b; Guilarte and McGlothan 1998; Ma et al. 1998; Savolainen et al. 1998) and cholinergic Minnema et al. 1988) systems.
The molecular basis for the effects of Pb 21 on neurotransmitter release remains poorly understood. It is thought that Pb 21 may alter normal synaptic activity by blocking presynaptic calcium (Ca 21 ) channels (Nachshen 1984; Suszkiw et al. 1984; Wang and Quastel 1991; Audesirk 1993; Audesirk and Audesirk 1993; activates PKC in part via the C2 domain (Tomsig and Suszkiw 1995; Sun et al. 1999) . PKC can indirectly modulate neurotransmitter release (Majewski and Iannazzo 1998) by increasing the size of the readily releasable pool of vesicles (Gillis et al. 1996) . Tomsig and Suszkiw (1990) have suggested that Pb 21 directly interacts with an intracellular target as a Ca 21 mimic in order to cause aberrant neurotransmitter release. They subsequently provided evidence (Tomsig and Suszkiw 1993 ) that neither PKC nor calmodulin were that target based on the speci®c inhibition of these proteins, with staurosporine and calmidazolium, respectively, in Pb 21 -induced neurotransmitter release assays. Numerous C2 domain and other Ca 21 -binding proteins besides PKC and calmodulin have been identi®ed (Nalefski and Falke 1996; Rizo and Su Èdhof 1998) . Some of these proteins are localized to the synaptic terminal and are directly involved in the regulation of neurotransmitter release.
We hypothesized that Pb 21 binds to and alters the binding characteristics of one of these proteins, synaptotagmin I. Synaptotagmin I is a C2 domain-containing protein that is localized to synaptic vesicles . Synaptotagmin I has a single transmembrane domain and a short intravesicular N-terminus. The majority of its cytoplasmic portion consists of two C2 domains (C2A and C2B) that are homologous to the C2 domain of PKC . Synaptotagmin I interacts with the plasma membrane protein syntaxin (Chapman et al. 1995; Kee and Scheller 1996; Shao et al. 1997) and negatively charged phospholipids such as phosphatidylserine and phosphatidylcholine (Chapman and Jahn 1994) . These interactions occur in a Ca 21 dependent manner via the C2A domain of synaptotagmin I.
We studied synaptotagmin I as a target of Pb 21 because of four prior observations. First, Pb 21 can alter neurotransmitter release by increasing spontaneous release and decreasing evoked release. Second, Pb 21 is known to potently activate PKC. Third, synaptotagmin I contains two C2 domains each of which are homologous to the C2 domain of PKC. Fourth, synaptotagmin I plays an integral role in neurotransmitter release. As evidence of this ®nal observation, a number of synaptotagmin I knockout and transgenic animals have been produced in species including M. musculus (Geppert et al. 1994; Neher and Penner 1994) , D. melanogaster (DiAntonio et al. 1993; Littleton et al. 1993; Broadie et al. 1994; DiAntonio and Schwarz 1994; Littleton et al. 1994) and C. elegans (Nonet et al. 1993) . Disruption of synaptotagmin I in these animal models causes a decrease in evoked release and sometimes causes an increase in spontaneous release (Littleton et al. 1993; Broadie et al. 1994; DiAntonio and Schwarz 1994; Littleton et al. 1994) .
We 
Experimental procedures
Recombinant proteins cDNA clones encoding both full and partial portions of the cytoplasmic domain of rat synaptotagmin I (synaptotagmin I 1±5 and 1±3) and syntaxin fused to a glutathione S-transferase (GST) tag were obtained from the laboratory of Dr Richard Scheller (Kee and Scheller 1996) . Sequencing of synaptotagmin I 1±5 nucleotide sequence identi®ed two inconsistencies with published synaptotagmin I sequence. Published sequence (Perin et al. 1990; Li et al. 1995) identi®es an aspartate encoded by nucleotide sequence 5 H -GAC-3 H at amino acid residue 374 while our clone encodes a glycine with nucleotide sequence 5 H -GGC-3 H at the same site. As an independent con®rmation, we veri®ed by sequence analysis that a fragment of synaptotagmin I cDNA that was PCR-ampli®ed from rat brain cDNA also coded for a glycine (5 H -GGC-3 H ) at amino acid 374 (data not shown) as previously shown (Davis et al. 1999; Osborne et al. 1999) . The second nucleotide in our sequence which did not match reported sequence was 5 H -ACT-3 H encoding a threonine at position 367, as opposed to a published isoleucine with nucleotide sequence 5 H -ATT-3 H . Both of these differences may re¯ect sequence polymorphisms.
Two mutant constructs of the synaptotagmin I 1±5 clone were produced with the Quikchange Mutagenesis kit (Stratagene, La Jolla, CA, USA). One mutant was constructed with a serine at amino acid position 230 (D230S). The sequences of the two HPLC-puri®ed primers used to produce this mutant were: 5 H -GGTGATGGCTGTGTATAGCTTTGATCGCTTCTCC-3 H and 5 H -GGAGAAGCGATCAAAGCTATACACAGCCATCACC-3 H . The other mutant construct contained a lysine at amino acid position 230 (D230K). The sequences of the two HPLC-puri®ed primers used to produce this mutant were 5
H -GGTGATGGCTGTG-TATAAGTTTGATCGCTTCTCC-3 H and 5 H -GGAGAAGCGAT-CAAACTTATACACAGCCATCACC-3
H . The mouse anti-rat monoclonal antibody ASV-48 (gift of Dr Richard Mains) detected both the D230S and the D230K mutant constructs of synaptotagmin I 1±5 by western blotting (data not shown).
Preparation of recombinant proteins was by growth and lysis of Escherichia coli bacteria containing wild-type and mutant constructs followed by precipitation of proteins with glutathione sepharose beads (Pharmacia, Piscataway, NJ, USA). Thrombin cleavage for one hour at room temperature was used to dissociate proteins from their GST tags. Sodium dodecyl sulfate±polyacryl-amide gel electrophoresis (SDS±PAGE) and Coomassie blue staining were used to con®rm the size, purity and concentration of the proteins.
Phospholipid binding assays
Tritiated phospholipid liposomes composed of lipid bilayers were prepared as previously described (Davletov and Su Èdhof 1993; Chapman and Jahn 1994 Phospholipid binding assays were performed as described (Chapman and Jahn 1994; Davletov and Su Èdhof 1993) . Chelator types and concentrations were calculated based on chelator±cation dissociation constants from Martell and Smith (1989) with the software program`Chelator' (Schoenmakers et al. 1992) . Chelators used were EGTA, nitrilotriacetic acid (NTA) and N-benzyiminodiacetic acid (N-BIDA). Phospholipid liposomes, synaptotagmin I 1±5, ASV-48 mouse anti-rat monoclonal synaptotagmin I antibody, Protein-G Sepharose (Pharmacia) and calculated concentrations of chelator and CaOAc or PbOAc were brought to a total volume of 100 mL with Buffer A. Reactions were incubated for 1 h at 258C. Samples were washed three times in 500 mL/wash with incubation buffer and then re-suspended in Ecolite scintillation¯uid. Levels of radioactivity in each sample were determined by liquid scintillation spectroscopy. Curves were ®tted to the data with the equation R R max Â M/EC 50 1 M as previously described by Tomsig and Suszkiw (1995) . R max is the maximum amount of phospholipid precipitated, [M] is the concentration of metal and EC 50 is the concentration of metal at which binding is half-maximal. The amount of radioactive isotope in 10 mL of labeled phospholipid was measured for each experiment. All experiments were performed in triplicate. In order to normalize our data, background levels of radioactivity (amount of radioactivity precipitated by synaptotagmin I 1±5 protein in the absence of cations) were subtracted from all measurements. Then, the amount of radioactivity precipitated in each condition was multiplied by 10 000 and divided by the total amount of radioactivity present in 10 mL of phospholipid liposomes.
Terbium metal binding assay Recombinant synaptotagmin I 1±5 GST-fusion protein was puri®ed from bacterial lysate using glutathione sepharose af®nity chromatography followed by the addition of thrombin protease to cleave the protein from the GST tag. Pure synaptotagmin I 1±5 protein was obtained by successive fractionation on a Superdex-75 gel ®ltration column equilibrated with 100 mm N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid (BES) (pH 7.4), 200 mm NaCl and 2 mm EDTA (Sutton et al. 1995) . Synaptotagmin I 1±5 protein was judged to be . 95% pure when visualized on a 15% SDS± PAGE gel. The puri®ed protein was exhaustively dialyzed against EDTA (2 mm) to remove metal ions and then into 10 mm Bis-Tris (pH 7.0) and 100 mm KCl. Bis-Tris was selected as a buffer because it weakly chelates Pb 21 (log b 4.3) (Scheller et al. 1980 ) and hence helps to prevent precipitation of Pb 21 hydroxides. In this way, the Bis-Tris mimics the natural metal-buffering role of glutathione in cells (Vallee and Wacker 1970; Kagi and Hapke 1984; Payne et al. 1999) . Amount of protein used was standardized by determination of the extinction coef®cient (280 29.5 mm 21 cm 2 1)(Keck Biophysical Facility, Yale University). Tb 31 binding titrations were performed according to the method developed by Horrocks and Sudnick (1981) that has been used to determine the af®nity of Pb 21 for the C2 domain of PKC (Walters and Johnson 1990) . Spectra were recorded by exciting the protein at 280 nm and measuring the¯uorescence from bound Tb 31 over the range of 470±570 nm in 1 nm increments with a 2-s integration time. Slit widths of 2 mm were used on the excitation and emission channels that corresponded to a bandwidth of 10 nm full-width at half maximum. A 455-nm cut-on ®lter was placed in the emission channel to block scattered light from the detector. At the end of representative titrations, the sample was centrifuged and the absorbance spectrum of the ®ltrate was checked to ensure that no protein precipitation had occured during the course of the titration. Fluorescence measurements were recorded with an ISS PC1¯uorimeter equipped with a cell holder thermostated at 258C and a computer-controlled autotitrator in the Keck Biophysics Facility, North western University. We further con®rmed that 0.5 mm Pb 21 did not alter the secondary structure of synaptotagmin I by performing circular dichroism measurements (wavelength 210 nm to 300 nm; Jasco J715 spectropolarimeter) using 1.6 mg/mL protein in 10 mm Tris HCl (pH 8), 25 mm NaCl at 208C (data not shown).
Synaptotagmin I/syntaxin co-immunoprecipitation
Co-immunoprecipitations of endogenous synaptotagmin I and syntaxin were performed in a manner similar to those previously described (Chapman et al. 1995) . One adult rat brain was homogenized in 10 mL of Buffer A containing 1% Triton-X-100 (Fisher Scienti®c, Pittsburgh, PA, USA) and protease inhibitors (0.5 mm phenylmethylsulfonyl¯uoride, 5 mg/mL aprotinin, 5 mg/ mL leupeptin and 5 mg/mL pepstatin A) with a Dounce homogenizer. The detergent-solubilized, cytosolic fraction was isolated by differential centrifugation for 15 min at 10 000 g with a JA-20 rotor in a Beckmann J2±21 centrifuge and then for 15 min in a TLA 120.2 rotor at 100 000 g in a Beckmann Optima TLX Ultracentrifuge. The sample was dialyzed in Spectra/Por (MWCO 6±8000) dialysis tubing for 48 h against two successive volumes of 2 L Buffer A. 5 mL of the mouse anti-rat monoclonal syntaxin antibody HPC-1 (Sigma, St Louis, MO, USA) or 5 mL of the mouse anti-rat monoclonal Golgi-localized 58K protein antibody were incubated with a bead volume of 20 mL Protein-G sepharose (Pharmacia) on ice for 30 min and subsequently with 300 mL of the dialyzed, detergent solubilized cytosolic fraction of rat brain homogenate in the presence of EGTA, Mg . Samples were incubated for 3 h on ice. Three 500 mL washes were performed with incubation buffer. Following the ®nal wash, sepharose beads were re-suspended in 10 mL of protein loading buffer, boiled for 10 min at 958C and electrophoresed on SDS± PAGE. Transfer of protein to nitrocellulose membrane was performed for 3 h at 50 V. Ponceau S staining was used to con®rm protein transfer and compare protein loading. The nitrocellulose membrane was rinsed in phosphate buffered saline with 0.1% Tween-20 (PBS-T) and then blocked for 20 min in 5% non-fat dry milk in PBS-T. Incubation with 1 : 1000 rabbit anti-rat polyclonal synaptotagmin I antibody VAS-SV008 (Stressgen, Collegeville, PA, USA) for 2 h at room temperature was followed by three 10 min washes in PBS-T. Incubation with protein-A peroxidase (Pierce, Rockford, IL, USA) conjugated secondary at 1 : 1000 or goat anti-rabbit peroxidase conjugated secondary (Jackson Immuno-research) at 1 : 10 000 for 1 h at room temperature was followed by three 10 min washes in PBS-T. Immersion in the chemiluminescent substrate ECL (Amersham, Pharmacia Biotech, Piscataway, NJ, USA) was followed by exposure to Kodak Biomax MR ®lm and subsequent ®lm development.
Co-immunoprecipitations of recombinant synaptotagmin I 1±5 and syntaxin were performed in a manner similar to those previously described (Kee and Scheller 1996) . 0.5 mg of the synaptotagmin I 1±5 and syntaxin proteins were combined with calculated volumes of chelator, cation(s), 20 mL bead volume of Protein-A sepharose beads and 2 mL of the rabbit polyclonal syntaxin antibody VAP-SV064 (Stressgen) in a total volume of 500 mL Buffer A. Reactions were incubated for 1 h on ice and subsequently washed three times with 500 mL of incubation buffer. The reactions were electrophoresed and western blotted as described above except that 1 : 1000 of the mouse anti-rat monoclonal synaptotagmin I antibody ASV-48 and 1 : 5000 of the goat anti-mouse antibody (Jackson Immuno-Research, West Grove, PA, USA) were used as the primary and secondary antibodies, respectively. Gel ®lms were digitized by scanning and saved as TIFF ®les. Intensity values for protein bands were calculated using the software package Scion Image (http://www.scioncorp.com). In order to standardize intensity values between experiments, the intensity for each synaptotagmin I band in a given experiment was multiplied by the average intensity for the syntaxin protein bands in that experiment (data not shown). In order to normalize the synaptotagmin I signal in Figs 8 and 9, the standardized synaptotagmin intensity values were divided by the intensity of each corresponding syntaxin protein band.
Protease protection assays
Protease protection assays of endogenous synaptotagmin I were performed as previously described (Davletov and Su Èdhof 1994) . Brie¯y, one adult rat brain was homogenized in 10 mL Buffer A containing 1% Triton-X-100 (Fisher) and 1 mm EGTA with a Dounce homogenizer. The cytosolic fraction of the homogenate was isolated by centrifugation as described above. Trypsin (5 mg/mL; Sigma) was added to samples and incubated at room temperature in the presence of approximate free concentrations of 1 mm Mg 21 , 11 mm Ca 21 and 2 mm Pb
21
. Digestions were stopped by addition of 5 mL of protein loading buffer, followed by boiling for 10 min at 958C. The reactions were electrophoresed and western blotted as described above using 1 : 1000 of the mouse anti-rat monoclonal synaptotagmin I antibody ASV-48 and 1 : 5000 of the goat anti-mouse antibody (Jackson ImmunoResearch) as the primary and secondary antibodies, respectively.
Protease protection assay of recombinant synaptotagmin I 1±3 was performed in a manner similar to that previously described (Davletov and Su Èdhof 1994) . Synaptotagmin I 1±3 (26 ng/mL) were combined with 66 ng/mL trypsin (Sigma), Buffer A and calculated amounts of chelator and cation in a total volume of 15 mL. Reactions were incubated at room temperature for 2 h and stopped by addition of 5 mL of protein loading buffer, followed by boiling for 10 min at 958C. The reactions were electrophoresed and western blotted as described above using 1 : 1000 of the mouse anti-rat monoclonal synaptotagmin I antibody ASV-48 and 1 : 5000 of the goat anti-mouse antibody (Jackson ImmunoResearch) as the primary and secondary antibodies, respectively. concentration used in initial experiments (85 mm) was chosen based on doses used in a previous study (Davletov and Su Èdhof 1993) , while the Pb 21 concentration (6 nm) was chosen based on the effects of lead on PKC (Markovac and Goldstein 1988a (Fig. 1) , while phospholipids were not precipitated in the absence of synaptotagmin I 1±5 under any cation condition (Fig. 1) . This suggests that the cation-dependent precipitation of phospholipid liposomes requires the synaptotagmin I 1±5 protein.
Results

Pb
Binding of synaptotagmin I 1±5 to [ half-maximal cation effect (EC 50 ) at a concentration of approximately 5 mm Ca 21 (Fig. 2) . This result is consistent with previous reports of an EC 50 of 3±6 mm Ca 21 (Davletov and Su Èdhof 1993; Li et al. 1995 (Fig. 3) . The D230K protein was unable to bind phospholipid in response to either 85 mm Ca 21 or 6 nm Pb 21 (Fig. 3) . From previous experiments we determined that the ASV-48 antibody used to precipitate synaptotagmin I proteins in these experiments was able to recognize both of the mutant proteins. This ®nding ruled out the possibility that the mutant proteins were not precipitated by the antibody during the experiment. These data suggest that single amino acid substitutions in the C2A domain of the synaptotagmin I 1±5 protein caused reductions in cation-dependent phospholipid binding. (Sutton et al. 1995; Sutton et al. 1999; Sutton RB, personal communication) and with the mutagenesis studies reported herein (Fig. 3) .
21 protects a fragment of synaptotagmin I from tryptic proteolysis Ca 21 induces a structural stabilization upon binding to the C2A domain of synaptotagmin I (Rizo and Su Èdhof 1998 ). This structural stabilization may explain the ability of Ca 21 to protect a ,32 kDa fragment of synaptotagmin I from tryptic proteolysis (Davletov and Su Èdhof 1994) . We tested whether Pb 21 as compared to Ca 21 can protect both recombinant and endogenous synaptotagmin I from tryptic proteolysis. physiologically relevant concentration range for each cation. Different concentrations of trypsin or incubation times will lead to variable amounts of protease protection of the synaptotagmin I fragment before the eventual full degradation of both protected and unprotected fragments. Under our conditions, we observed the protection of a fragment of the synaptotagmin I 1±3 protein in the presence of 500 mm or more Ca 21 (Fig. 6a) . Pb 21 was able to protect synaptotagmin I 1±3 from proteolytic cleavage at concentrations ®ve orders of magnitude lower than Ca 21 , starting at a concentration of 8 nm (Fig. 6b) . Because there are only two proteins present during the recombinant protease protection assay, synaptotagmin I and trypsin, these results indicate that Pb 21 is able to bind directly to the synaptotagmin I protein to protect a fragment from proteolytic cleavage. Furthermore, because the synaptotagmin I 1±3 protein only contains the C2A domain of synaptotagmin I, these results suggest that the Pb 21 -mediated protease protection of synaptotagmin I involves a direct interaction of Pb 21 with the C2A domain of synaptotagmin I.
21 fails to induce the interaction of synaptotagmin I and syntaxin The binding of synaptotagmin I to syntaxin is enhanced by Ca 21 (Chapman et al. 1995; Kee and Scheller 1996; Shao et al. 1996; Shao et al. 1997) . We compared the effects of Ca 21 vs. Pb 21 on the co-immunoprecipitation of both recombinant and endogenous synaptotagmin I and syntaxin proteins. In order to investigate the interaction of endogenous rat brain synaptotagmin I and syntaxin, a monoclonal syntaxin antibody was used to immunoprecipitate syntaxin from rat brain homogenate followed by the detection of synaptotagmin I by western blotting. In the presence of total concentrations of either 5 mm EGTA or 500 mm Mg 21 a low level of cation-independent synaptotagmin I/syntaxin binding was observed in rat brain homogenate as previously described (Chapman et al. 1995) . 500 mm Ca 21 caused an enhanced level of binding of synaptotagmin I to syntaxin as expected. However, 500 mm Pb 21 failed to enhance synaptotagmin I co-immunoprecipitation with syntaxin ( Fig. 7) . High concentrations of both Ca 21 and Pb 21 were used because it was assumed that cation-binding proteins present in the homogenate would chelate a large proportion of each of these cations. Immunoprecipitation with a nonspeci®c monoclonal mouse antibody for the Golgi-localized . Western blotting detected the synaptotagmin I protein (,65 kDa) using the rabbit anti-rat polyclonal antibody VAS-SV008 (Stressgen). Synaptotagmin I was not detected in the absence of primary antibody or in the presence of a non-speci®c mouse anti-rat monoclonal antibody to the Golgi-speci®c 58K protein indicating the speci®city of the immunoprecipitation. A low level of cation-independent binding was observed in the presence of either 5 mM EGTA or 500 mM Mg rat 58K protein or with no primary antibody failed to precipitate synaptotagmin I or syntaxin.
We performed co-immunoprecipitations of recombinant synaptotagmin I 1±5 and syntaxin so that we could examine the interaction of the proteins across physiologically relevant concentration ranges of both Ca 21 and Pb
21
. In agreement with the endogenous co-immunoprecipitation results, there was only a small degree of cation-independent binding in no cation or 1 mm Mg 21 conditions (Figs 8a and  b) . In agreement with a previous report (Kee and Scheller 1996) , speci®c free Ca 21 concentrations from 200 mm to 1 mm were able to enhance the binding of synaptotagmin I 1±5 and syntaxin (Figs 8a and b) . However, reactions containing physiologically relevant free concentrations of Pb 21 ranging from 6 pm to 500 nm did not display enhanced binding of synaptotagmin I 1±5 to syntaxin (Figs 8a  and b) .
Given the results of both our endogenous and recombinant synaptotagmin I and syntaxin co-immunoprecipitation (Leveque et al. 2000; Verona et al. 2000) have suggested that Ca 21 may dissociate synaptotagmin I from the t-SNARE core complex, which includes syntaxin. Alternatively, a number of previous studies suggest that Ca 21 can induce, not dissociate, the interaction of synaptotagmin I and syntaxin (Chapman et al. 1995; Kee and Scheller 1996; Shao et al. 1997) . Our studies also suggest that Ca 21 promotes the interaction between these two proteins. Further experimentation, beyond the scope of this work, will be required in order to resolve these discrepancies and elucidate the full extent of the effects of Ca 21 on the interaction of synaptotagmin I and syntaxin in vivo. Unlike Ca 21 , Pb 21 was unable to induce the binding of these proteins at any concentration tested even though similar concentrations of Pb 21 were suf®cient to potently protect synaptotagmin I 1±3 from proteolytic cleavage and to induce the binding of the synaptotagmin I to phospholipid. Our results suggest that even though Pb 21 was able to directly bind to synaptotagmin I at low nanomolar concentrations, it was unable to induce the binding of the synaptotagmin I to syntaxin. -dependent binding characteristics at nanomolar concentrations. In particular, Pb 21 promotes the binding of synaptotagmin I to phospholipids, but impairs the ability of synaptotagmin I to bind to syntaxin. These differences in effects of Pb 21 on synaptotagmin I may be due to conformational (Garcia et al. 2000) or electrostatic changes 
